Publications

Found 2 results
Filters: Author is X.-M. You  [Clear All Filters]
2012
Y. - Y. Mi, Zhu, L. - J., You, X. - M., and Wu, S., Clarification of data for a meta-analysis: p53 codon 72 polymorphism and prostate cancer risk, vol. 11. pp. 1958-1959, 2012.
Hirata H, Hinoda Y, Kikuno N, Kawamoto K, et al. (2007). CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin. Cancer Res. 13: 5056-5062. http://dx.doi.org/10.1158/1078-0432.CCR-07-0859 PMid:17785557   Hirata H, Hinoda Y, Kikuno N, Suehiro Y, et al. (2009). Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy. J. Urol. 181: 1907-1912. http://dx.doi.org/10.1016/j.juro.2008.11.093 PMid:19237173   Li MS, Liu JL, Wu Y, Wang P, et al. (2011). Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk. Genet. Mol. Res. 10: 2924-2933. http://dx.doi.org/10.4238/2011.November.29.3 PMid:22179964   Ricks-Santi L, Mason T, Apprey V, Ahaghotu C, et al. (2010). p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate 70: 1739-1745. PMid:20593380 PMCid:3057117   Wu WJ, Kakehi Y, Habuchi T, Kinoshita H, et al. (1995). Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers. Jpn. J. Cancer Res. 86: 730-736. http://dx.doi.org/10.1111/j.1349-7006.1995.tb02461.x PMid:7559095   Xu B, Xu Z, Cheng G, Min ZC, et al. (2010). Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese. Cancer Genet. Cytogenet. 202: 76-81. http://dx.doi.org/10.1016/j.cancergencyto.2010.02.014 PMid:20875869   Xu B, Tong N, Chen SQ, Yang Y, et al. (2012). Contribution of HOGG1 Ser326Cys polymorphism to the development of prostate cancer in smokers: meta-analysis of 2779 cases and 3484 controls. PLoS One 7: e30309. http://dx.doi.org/10.1371/journal.pone.0030309 PMid:22279581 PMCid:3261179